Stockalyze
Example report. Sign up to run the same analysis on any ticker.
SPCX logoSPCXEquity research

Report date: 2026-11-15

$129.46-8.97 (-6.48%)Live · delayed quote, informational only

Analysis focus

Provide a balanced, comprehensive analysis: fundamentals and valuation, the Wall Street view, technical posture, and the key forward risks and catalysts.

Summary

Fundamentals and valuation: SPCX has posted very fast growth, but its profits are still thin when one-time items are taken out, and its valuation is high. Q3 2026 revenue was reported at $14.58B, up 161% year over year, against a $12.59B consensus. EPS was $0.35 against expectations of $0.10-$0.11 [4][13]. This followed a Q2 with $7.81B of revenue and a $541M net loss [4]. The headline Q3 net income of $4.4B needs adjusting. About $2.3B of it came from non-operating and tax items: $0.9B of interest income, $1.0B of other income and a $0.4B tax benefit. Operating income of $2.8B (a 19.1% margin) is the cleaner measure, so roughly half of reported profit did not come from operations [18]. On a trailing basis, net margin is still negative (-8.6%), so P/E is not meaningful. The shares trade at about 59x TTM revenue of $32.04B and an estimated ~133x EV/EBITDA [17], at a market cap of about $1.89T [11][12]. Other snapshots put the multiple at about 63x trailing sales in late August [4] and about 45x estimated 2026 sales in July [11]. Cash flow is the central tension. TTM free cash flow was about -$39.2B on $55.0B of capex, $19.6B of it in Q3 alone. That is cushioned by about $89.9B of cash and securities, or about $51.0B of net cash [14]. Looking ahead, Morgan Stanley does not expect positive FCF before 2035 as capex rises toward $300B a year by 2031, and Goldman estimates about $270B of debt will need to be raised over 2026-2030 [15]. Reported guidance of $100B annualized revenue by end-2026 and $33-37B in Q1 2027 [21] would be a major catalyst if met, but it is a large execution step up from Q3 and has only low-confidence sourcing. The Wall Street view: sell-side sentiment is clearly positive but the targets are very far apart. The S&P Global panel of 40 analysts shows 24 Strong Buy, 8 Buy, 6 Hold, 0 Sell and 2 Strong Sell [9]. The average target is $256.41 and the median $245, implying about 84% and 76% upside, within a range of $70 to $800 [2]. Recent actions are mostly reiterations rather than upgrades: Deutsche Bank at $250, Stifel at $190, and Bank of America kept its Buy without a published target [10]. Goldman raised its target to $230 from $205 [3]. Post-Q3 reports also have TD Cowen at $224 and Morgan Stanley at $300, and say JPMorgan raised to $500 from $240 [8]. The JPMorgan figure itself is unconfirmed [3]. The bearish minority includes Phillip Securities at Sell/$75 (about 46% below the price) and DZ Bank's August cut to Sell [16]. The tension is that the stock closed at $139.11 on November 13. That is only about 3.0% above the $135 IPO price and about 38% below the $225.64 all-time high [1]. It is also roughly flat against the late-August close of $137.95, even though targets were raised [5]. The market has not adopted the sell-side's optimism. Technical posture and forward risks: the price is neutral to weak, and share supply weighs heavily. SPCX sits just above its 50-day SMA ($137.80) and just below its 50-day EMA ($139.93). It is about 6% below a 200-period SMA of $147.34, with RSI(14) at 46.1, and Investing.com's moving-average summary reads 'Strong Sell' [19]. The $135 IPO price has acted as a pivot. Shares dipped to about $123.62 on November 5 and then recovered to $139-$142 [6]. Resistance is near $171.92 (the October 6 high) and $225.64, and support is at the $104.83 52-week low [6]. The price is also down from $147.49 on October 23 [12]. The main near-term event is the December 8 lockup expiry of up to about 797.6M shares (over $110B), following earlier tranches of 911.5M, 319M and up to 1.3B shares [7]. Option-implied volatility near 59% compares with about 69% realized [11], and beta is 3.18 [12]. A political catalyst also hangs over the stock. The roughly 13% two-session drop after the November 3 midterms was tied to a Texas governor-elect who campaigned on pausing new data-center construction, which bears on SpaceX's AI-infrastructure plans [20]. Bulls point to the Q3 beat, AI revenue above $7.5B [4], strong analyst support and a large net cash position. Bears point to extreme multiples, deeply negative FCF with large future funding needs, earnings boosted by non-operating items, and heavy pending supply. The evidence supports neither case decisively, and the reader should weigh these factors themselves.

Findings (22)

SPCX closed at $139.11 on November 13, 2026 (down 0.59% that day), about 3.0% above its June 2026 IPO price of $135, about 38% below its all-time high of $225.64, and 33% above its 52-week low of $104.83; true 6-month and 12-month returns cannot be calculated because the stock has traded for only about 5 months.

High confidence

Investing.com and the Motley Fool quote box both show a $139.11 close on 11/13/26, and the Fool lists a $104.83–$225.64 52-week range against a $135 IPO price. TipRanks dates the $135 IPO to June 2026, so no 6- or 12-month price history exists yet; the since-IPO figure is calculated as 139.11/135.

The average 12-month target is $256.41 and the median is $245, with a range of $70 to $800; against the $139.11 close on Nov 13, 2026, that implies about 84% (average) and 76% (median) upside.

High confidence

StockAnalysis lists the average, median, low and high targets and the Nov 13 close; the upside figures are calculated from those. Consensus depends on the provider: in late August, TipRanks' average was $232.35 (range $75-$800) and Investing.com's range was $75-$450.

Goldman Sachs started at Buy with a $205 target in July 2026 and raised it to $230 around Oct 14, 2026 (about 65% above $139.11), while JPMorgan has a Buy at $240 (about 73% above).

Medium confidence

Quartz reported Goldman's $205 starting target and Advanced Television reported the raise to $230; IBTimes (Aug 27) and AskFuzz report JPMorgan's $240 target. A Stocktwits table after Q3 seemed to show JPMorgan at $240/$500 with unlabeled columns, and a July report cited $225, so the current JPMorgan figure is not confirmed. All are secondary sources.

Q3 2026 revenue was reportedly $14.575B against an expected $12.59B, and EPS was $0.35 against an expected $0.11; Q2 revenue was $7.81B (up 92% year on year) with a $541M net loss, and the shares traded at about 63x trailing sales in late August.

Medium confidence

Shacknews and InvestingLive report the Q3 beat, with AI revenue above $7.5B; RTTNews reports Q3 turned to a profit; IBTimes gives the Q2 figures and the ~63x price-to-sales multiple. No 10-Q or 8-K was checked, so it is unconfirmed whether the swing to profit includes one-time items, and the Q3 report date conflicts across sources. There is no 5-year history for comparison because the stock only listed in June 2026.

SPCX closed at $139.11 on Nov 13, 2026 ($136.26 after hours), 38% below its post-IPO high of $225.64 from four days after the June 2026 listing, and close to its late-August level of $137.95.

High confidence

StockAnalysis gives the Nov 13 close and after-hours price; IBTimes gives the $225.64 peak and the Aug 26 close of $137.95. The distance from the peak is calculated, and the comparison shows the price roughly flat for about three months despite target raises.

In price-level terms, the $135 IPO price has acted as a pivot: shares fell to about $123.62 on November 5, 2026 (from $135.92), then recovered to about $139–$142 by November 9–13; the October 6 high near $171.92 and the $225.64 all-time high are the overhead resistance levels; and $104.83 (the 52-week low) is the lower support level.

Medium confidence

The Fool reports a slide below the $135 IPO price followed by a 7.3% rebound on Nov 6, and Marketchameleon shows a $141.31 close on Nov 3. The Oct 6 $171.92 high and the $123.62 low on Nov 5 come from aggregator summaries in search results and could not be confirmed on a primary price feed. Investing.com's daily classic pivots (S1 $139.68 / R1 $140.59) are too tight to work as strategic levels.

Share supply is the main technical overhang: about 911.5 million shares unlocked on August 6, 2026, about 319 million in late August, and up to 1.3 billion two business days after the October 20 Q3 report (the stock fell about 5% that day); the remainder of the 180-day lockup, up to about 797.6 million shares (over $110 billion), expires on December 8, 2026.

Medium confidence

TIKR and TipRanks give the August tranche sizes and note that Musk's roughly 6.4 billion shares stay locked until mid-2027. Coingape and the search summaries describe the post-Q3 1.3 billion-share unlock and the roughly 5% drop, and FutureSearch gives the Dec 8 date and the 797.6 million shares. These are secondary sources; the 424B prospectus or the 10-Q should be checked to confirm the dates.

The Wall Street view is constructive but widely dispersed: an earlier consensus was 'Moderate Buy' (23 Buy, 6 Hold, 2 Sell) with a $232.11 average target; Koyfin consensus was about $222.42 before the Q3 report; and reported post-Q3 actions include JPMorgan raising its target to $500 from $240 (Overweight), TD Cowen to $224 from $200, and Morgan Stanley at $300 (Overweight), within a range of about $190–$800.

Medium confidence

TipRanks gives the rating breakdown and the $232.11 average from its August article; the individual broker target changes come from secondary summaries and were not checked against broker notes. Mizuho and Macquarie reiterated Outperform ratings around lockup dips.

As of November 2026, 40 analysts in the S&P Global panel cover SPCX with a 'Buy' consensus: 24 Strong Buy, 8 Buy, 6 Hold, 0 Sell and 2 Strong Sell.

High confidence

StockAnalysis's forecast page shows these Nov '26 rating counts from S&P Global. Earlier panels were smaller: IBTimes cited TipRanks' 32 analysts in August (24 buy, 5 hold, 3 sell), which suggests coverage has grown and stayed mostly positive.

Other recent bank actions are mostly reiterations, not upgrades: Deutsche Bank reiterated Buy at $250 on Nov 6, 2026 (about 80% above the current price), Stifel reiterated Buy at $190 on Nov 9 (about 37% above), and Bank of America kept a Buy on Nov 10 without a published target.

High confidence

StockAnalysis shows these as 'Reiterates' or 'Maintains' with dates and targets; the percentages are calculated against the $139.11 Nov 13 close. No major-bank downgrade appeared in the last 90 days in the sources found.

Valuation and volatility are high: Insider Monkey put SPCX at about 45x estimated 2026 sales in July 2026, the Motley Fool lists a market cap of about $1.89 trillion, and FutureSearch cites option-implied volatility near 59% against about 69% realized volatility heading into the December 8 unlock.

Medium confidence

Insider Monkey gives the roughly 45x 2026-sales multiple at a valuation of about $1.6 trillion; the Fool quote box shows a $1.89 trillion market cap; FutureSearch reports about 59% implied and about 69% historical volatility. A ~5-year own-history comparison is not possible for a stock that listed in June 2026, and no peer multiple (for example Rocket Lab) was verified within the search budget.

SPCX (Space Exploration Technologies Corp., Nasdaq) closed at $139.11 on November 13, 2026, giving a market cap of about $1.89 trillion. That price is down from $147.49 on October 23, 2026, and sits about 38% below the 52-week high of $225.64 and about 33% above the 52-week low of $104.83.

Medium confidence

The Motley Fool quote page shows the $139.11 close on Nov 13, 2026, a $1.89T market cap, the 52-week range and a beta of 3.18. Its market cap counts publicly traded shares only. Other aggregators show different market caps (about $2.0T on Robinhood), so the market cap is less certain than the price.

In Q3 2026 (quarter ended September 2026, reported October 20), SPCX posted revenue of $14.58B, up 161% year over year, and EPS of $0.35. Consensus was $12.59B and $0.10.

Medium confidence

Shacknews reports the EPS and revenue beat against consensus. The sec-api.io analysis of the filing confirms revenue of $14.6bn, up 161% year over year. Both are secondary sources; the company's 10-Q is the primary document to confirm against.

SPCX's free cash flow is deeply negative. TTM FCF was about -$39.2B, driven by $55.0B of TTM capex, including $19.6B in Q3 2026 alone. At September 30, 2026 the company held $89.9B of cash and securities against roughly $38.8B to $39.2B of total debt, or about $51.0B of net cash.

Medium confidence

sec-api.io gives TTM FCF of ($39.2bn), TTM capex of $55.0bn, cash and securities of $89.9bn and net cash of $51.0bn. The Fool page shows TTM FCF of -$39.27B and total debt of $38.84B to $39.22B, though its cash figures are internally inconsistent.

The main forward risk for SPCX is funding. Morgan Stanley projects capex rising toward $300B a year by 2031 and does not expect positive free cash flow before 2035. Goldman Sachs estimates about $270B of debt capital will need to be raised between 2026 and 2030.

Medium confidence

Secondary coverage quotes Morgan Stanley's capex and FCF timeline and Goldman's 2026-2030 debt-raising estimate. Together these mean future dilution or leverage is a key variable alongside revenue growth.

Bearish coverage is a small minority: Phillip Securities repeated a Sell with a $75 target in August 2026 (about 46% below $139.11), DZ Bank cut to Sell on Aug 20, and the S&P panel's lowest target is $70 (about 50% below).

Medium confidence

IBTimes names Phillip Securities (Glenn Thum) at Sell/$75 and DZ Bank's Aug 20 cut to Sell. StockAnalysis shows a $70 low target and 2 Strong Sell ratings. These bear calls are from August and may have been updated since.

Standard earnings multiples are not meaningful for SPCX. Trailing P/E is not meaningful because TTM net income is negative (-8.6% net margin), and the dividend yield is 0.00%. Based on the quote page's own figures, the stock trades at about 59x TTM revenue of $32.04B and an estimated EV/EBITDA of about 133x (EV ≈ $1.84T against TTM EBITDA of $13.81B).

Medium confidence

The page reports TTM EPS of $0.00, a dividend yield of 0.00%, gross margin of 56.74% and operating margin of -2.01%. P/S and EV/EBITDA are derived from its market cap, debt, cash, revenue and EBITDA figures, and the page does not publish them directly. No forward P/E or P/B was available. SPCX only listed in mid-2026, so there is no 5-year multiple history to compare against, and no peer metrics (such as Rocket Lab's) turned up in the searches.

Q3 2026 net income of $4.4B was flattered by about $2.3B of non-operating and tax items: $0.9B of interest income, $1.0B of other income and a $0.4B tax benefit. Operating income of $2.8B (19.1% margin) is the cleaner measure of core profit.

Medium confidence

The sec-api.io breakdown lists operating income of $2.8bn (against $0.3bn in Q3 2025) separately from the interest income, other income and tax benefit that lift net income to $4.4bn. That means roughly half of reported net income did not come from operations.

On November 13, 2026, SPCX ($139.11) sat just above its 50-day simple moving average of $137.80 and just below its 50-day exponential MA of $139.93, and roughly 6% below its 200-period simple MA of $147.34 (exponential $144.03), with RSI(14) at 46.1 (neutral).

Medium confidence

The Investing.com technical page, timestamped Nov 14, 2026, lists RSI(14) 46.079 'Neutral', MA50 137.80/139.93 and MA200 147.34/144.03, with an overall 'Strong Sell' summary (1 Buy, 11 Sell across moving averages). Confidence is medium because a stock listed for only about 5 months does not have 200 daily sessions, so the 200-period figure is probably calculated on a shorter or partial history, and the page warns that its data may not be real-time.

The early-November decline (about 13% over two sessions) followed the November 3, 2026 midterm results, in which Democrats won the Texas Senate seat and governorship; the governor-elect had campaigned partly on pausing new data-center construction, which bears on SpaceX's AI-infrastructure plans.

Medium confidence

The Motley Fool's Nov 6 article attributes the roughly 13% two-session drop to the midterm sweep, a possible data-center pause and expected scrutiny of Musk's companies, and notes Musk's reported $474 million in political donations. This is a news and political catalyst, not a fundamental one.

Company guidance reportedly calls for $100B of annualized revenue by end-2026 and Q1 2027 revenue of $33B to $37B. That would be more than double Q3 2026's $14.58B, making it a major near-term catalyst and also a major execution risk.

Low confidence

The guidance figures come from an Investing.com summary of the earnings call, not from the company's 8-K. The jump from Q3 levels is large enough that the figures should be checked against the primary release.

SpaceX reportedly posted record Q3 2026 results on October 20, with revenue up 161% to $14.58 billion and net income of $4.4 billion, $89.9 billion of cash at September 30, and Q4 capex guidance of $35–40 billion; no one-time items were identified in the sources reviewed.

Low confidence

The revenue and net-income figures appear in search-result summaries of post-Q3 coverage but could not be traced to a fetched primary 8-K or earnings release. FutureSearch supplies the cash and capex figures. The revenue growth rate likely reflects consolidated or merged entities and should be normalized against the 8-K before any comparison with the $18.67 billion of 2025 sales cited by Insider Monkey.

Sources (30)

Caveats

Time sensitivity: prices are as of the November 13, 2026 close (after-hours $136.26 [5]). The December 8 lockup expiry [7] could change the technical picture significantly. Several bear calls and consensus snapshots date from August and may be out of date [8][16]. Data quality: most fundamentals come from secondary aggregators (Shacknews, sec-api.io, Motley Fool, StockAnalysis), and the 10-Q and 8-K were not checked directly [4][13][22]. Sources conflict on the Q3 EPS consensus ($0.10 vs $0.11) [4][13] and on the Q3 report date [4]. JPMorgan's current target ($240 vs $500) is unconfirmed [3][8]. Market cap differs by provider ($1.89T vs about $2.0T) [12], and the Fool's cash figures are internally inconsistent [14]. Finding [22] states that no one-time items were identified, but [18] shows about $2.3B of non-operating and tax benefits in Q3 net income. The 161% revenue growth may reflect consolidated or merged entities and should be normalized before comparing it with 2025 sales [22]. The forward guidance [21] comes from a low-confidence call summary. The ~$171.92 and $123.62 price levels could not be confirmed on a primary feed [6]. The 200-period moving average is likely based on fewer than 200 sessions [19]. Lockup tranche sizes and dates need confirming against the 424B prospectus [7]. Gaps: the stock has only about 5 months of trading history, so there are no true 6- or 12-month returns and no ~5-year valuation comparison [1][17]. No peer multiple (such as Rocket Lab) was verified [11][17]. Forward P/E and P/B were unavailable [17]. Segment-level unit economics, competition, regulatory and launch-execution risk, governance and key-person risk around Musk beyond the lockup and political-scrutiny points [7][20], and dilution modeling are not covered. This is not investment advice.

This report is for informational purposes only and is not investment advice. No buy / sell / hold recommendation is made or implied.

More research reports

Recent reports from the same pipeline. See all examples

Want this on your watchlist?

Add your own focus, pick a delivery speed, and get a source-verified report like this one.